Eris Biotech (YC W24)
Evita Weagel, Ph.D. is the Co-Founder & CEO of Eris Biotech with a background in Microbiology and Molecular Biology. Evita has held various positions in research and academia, including roles at Sumitomo Pharma Oncology, Brigham Young University, and Tolero Pharmaceuticals, Inc. Evita has also been involved in summer research fellowships and has pursued additional education in Data Science and Business Analytics.
This person is not in any teams
Eris Biotech (YC W24)
At Eris Biotech, we're pioneering a revolution in cancer care. Our innovative treatments specifically target the tumor microenvironment, ensuring maximum effectiveness with minimal side effects. We're not just developing medicine, we're crafting hope. Join us in shaping a healthier future.